Compass Therapeutics, Inc. (CMPX) Tops Q1 EPS by 3c

Compass Therapeutics, Inc. (NASDAQ: CMPX) reported Q1 EPS of ($0.08), $0.03 better than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Compass Therapeutics, Inc. (CMPX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Waste stocks ride AI and healthcare boom as CLH surges 27%
• RBC Capital Downgrades Bucher Industries AG (BUCN:SW) (BCHHF) to Sector Perform